Clinical implication of thiopurine methyltransferase polymorphism in children with acute lymphoblastic leukemia: A preliminary Egyptian study

Background: 6-mercaptopurine (6-MP) is an essential component of pediatric acute lymphoblastic leukemia (ALL) maintenance therapy. Individual variability in this drug-related toxicity could be attributed in part to genetic polymorphism thiopurine methyltransferase (TPMT). Aim: To investigate the fre...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Farida H El-Rashedy, Seham Mohammed Ragab, Ashraf A Dawood, Shaymaa A Temraz
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2015-01-01
Saila:	Indian Journal of Medical and Paediatric Oncology
Gaiak:	6-mercaptopurine acute lymphoblastic leukemia pharmacogenetic polymorphism thiopurine methyltransferase
Sarrera elektronikoa:	http://www.ijmpo.org/article.asp?issn=0971-5851;year=2015;volume=36;issue=4;spage=265;epage=270;aulast=El-Rashedy
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!